Clover Health Investments Corp

Insider activity at Clover Health shows routine tax‑related sales by CEO Jamie Reynoso, confirming stable governance and no imminent stock‑price impact.

Insider buying signals a shift at Clover Health: CEO Patrick’s RSU purchase hints at long‑term confidence amid a low stock price and Medicare‑focused strategy.

Insider buys at Clover Health signal long‑term confidence amid a volatile market – see why CEO Jamie L.’s 159‑k‑share purchase could hint at a rebound.

CEO Jamie Reynoso’s recent insider sale of 5,833 Clover Health shares hints at cautious confidence as the stock faces a steep 48 % YTD decline, prompting investors to watch for future turnaround signals.

CEO Jamie Reynoso’s recent sale of 5,833 shares at $1.91 shows a strategic move amid Clover Health’s 48% YTD decline—investors should watch future Form 4 filings for insights on insider confidence and potential turnaround.

Insider sale by Clover Health CEO shows cautious outlook; evaluate negative earnings & liquidity dip as potential buying signal.

Garipalli Vivek’s latest Clover Health share purchase signals insider confidence, revealing why top shareholders buy during vesting and what it means for investors.

Insider buying shows confidence in Clover Health’s Medicare strategy—Armbrister adds 79,365 shares, backing long‑term growth amid market volatility.

Insider selling shows Clover Health CEO’s disciplined plan amid a 30% stake reduction and a volatile, low‑price cycle—what this means for investors.